277 related articles for article (PubMed ID: 35973530)
21. Internal exposure to perfluoroalkyl substances (PFAS) in vegans and omnivores.
Menzel J; Abraham K; Dietrich S; Fromme H; Völkel W; Schwerdtle T; Weikert C
Int J Hyg Environ Health; 2021 Aug; 237():113808. PubMed ID: 34298317
[TBL] [Abstract][Full Text] [Related]
22. Associations between serum per- and polyfluoroalkyl substances as mixtures and lipid levels: A cross-sectional study in Jinan.
Liu Y; Zhang H; Xu F; Zhang X; Zhao N; Ding L
Sci Total Environ; 2024 May; 923():171305. PubMed ID: 38423340
[TBL] [Abstract][Full Text] [Related]
23. Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels.
Mora AM; Fleisch AF; Rifas-Shiman SL; Woo Baidal JA; Pardo L; Webster TF; Calafat AM; Ye X; Oken E; Sagiv SK
Environ Int; 2018 Feb; 111():1-13. PubMed ID: 29156323
[TBL] [Abstract][Full Text] [Related]
24. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project.
Frisbee SJ; Shankar A; Knox SS; Steenland K; Savitz DA; Fletcher T; Ducatman AM
Arch Pediatr Adolesc Med; 2010 Sep; 164(9):860-9. PubMed ID: 20819969
[TBL] [Abstract][Full Text] [Related]
25. The Association Between Perfluoroalkyl Substances and Lipids in Cord Blood.
Spratlen MJ; Perera FP; Lederman SA; Robinson M; Kannan K; Herbstman J; Trasande L
J Clin Endocrinol Metab; 2020 Jan; 105(1):43-54. PubMed ID: 31536623
[TBL] [Abstract][Full Text] [Related]
26. Perfluoroalkyl substance mixtures and cardio-metabolic outcomes in highly exposed male workers in the Veneto Region: A mixture-based approach.
Batzella E; Girardi P; Russo F; Pitter G; Da Re F; Fletcher T; Canova C
Environ Res; 2022 Sep; 212(Pt A):113225. PubMed ID: 35390304
[TBL] [Abstract][Full Text] [Related]
27. Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years.
Dunder L; Lind PM; Salihovic S; Stubleski J; Kärrman A; Lind L
Environ Res; 2022 Aug; 211():112903. PubMed ID: 35231461
[TBL] [Abstract][Full Text] [Related]
28. Associations of Perfluoroalkyl Substances with Prevalence of Metabolic Syndrome in Highly Exposed Young Adult Community Residents-A Cross-Sectional Study in Veneto Region, Italy.
Zare Jeddi M; Dalla Zuanna T; Barbieri G; Fabricio ASC; Daprà F; Fletcher T; Russo F; Pitter G; Canova C
Int J Environ Res Public Health; 2021 Jan; 18(3):. PubMed ID: 33572770
[TBL] [Abstract][Full Text] [Related]
29. The association between PFOA, PFOS and serum lipid levels in adolescents.
Geiger SD; Xiao J; Ducatman A; Frisbee S; Innes K; Shankar A
Chemosphere; 2014 Mar; 98():78-83. PubMed ID: 24238303
[TBL] [Abstract][Full Text] [Related]
30. Associations of single and multiple perfluoroalkyl substances exposure with folate among adolescents in NHANES 2007-2010.
Tian Y; Luan M; Zhang J; Yang H; Wang Y; Chen H
Chemosphere; 2022 Nov; 307(Pt 3):135995. PubMed ID: 35981617
[TBL] [Abstract][Full Text] [Related]
31. Human exposure pathways to poly- and perfluoroalkyl substances (PFAS) from indoor media: A systematic review protocol.
DeLuca NM; Angrish M; Wilkins A; Thayer K; Cohen Hubal EA
Environ Int; 2021 Jan; 146():106308. PubMed ID: 33395950
[TBL] [Abstract][Full Text] [Related]
32. Prenatal exposures to perfluoroalkyl acids and serum lipids at ages 7 and 15 in females.
Maisonet M; Näyhä S; Lawlor DA; Marcus M
Environ Int; 2015 Sep; 82():49-60. PubMed ID: 26010307
[TBL] [Abstract][Full Text] [Related]
33. Lipoprotein profiles associated with exposure to poly- and perfluoroalkyl substances (PFASs) in the EuroMix human biomonitoring study.
Papadopoulou E; Nicolescu A; Haug LS; Husøy T; Deleanu C; Dirven H; Lindeman B
Environ Pollut; 2022 Sep; 308():119664. PubMed ID: 35738521
[TBL] [Abstract][Full Text] [Related]
34. The association between total serum isomers of per- and polyfluoroalkyl substances, lipid profiles, and the DNA oxidative/nitrative stress biomarkers in middle-aged Taiwanese adults.
Lin CY; Lee HL; Hwang YT; Su TC
Environ Res; 2020 Mar; 182():109064. PubMed ID: 31884197
[TBL] [Abstract][Full Text] [Related]
35. Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010.
Khalil N; Chen A; Lee M; Czerwinski SA; Ebert JR; DeWitt JC; Kannan K
Environ Health Perspect; 2016 Jan; 124(1):81-7. PubMed ID: 26058082
[TBL] [Abstract][Full Text] [Related]
36. Reductions in serum lipids with a 4-year decline in serum perfluorooctanoic acid and perfluorooctanesulfonic acid.
Fitz-Simon N; Fletcher T; Luster MI; Steenland K; Calafat AM; Kato K; Armstrong B
Epidemiology; 2013 Jul; 24(4):569-76. PubMed ID: 23685825
[TBL] [Abstract][Full Text] [Related]
37. The association between blood PFAS concentrations and clinical biochemical measures of organ function and metabolism in participants of the Canadian Health Measures Survey (CHMS).
Cakmak S; Lukina A; Karthikeyan S; Atlas E; Dales R
Sci Total Environ; 2022 Jun; 827():153900. PubMed ID: 35218824
[TBL] [Abstract][Full Text] [Related]
38. Serum perfluoroalkyl substances in relation to lipid metabolism in Chinese pregnant women.
Yang J; Wang H; Du H; Fang H; Han M; Xu L; Liu S; Yi J; Chen Y; Jiang Q; He G
Chemosphere; 2021 Jun; 273():128566. PubMed ID: 33097232
[TBL] [Abstract][Full Text] [Related]
39. The concentration of several perfluoroalkyl acids in serum appears to be reduced by dietary fiber.
Dzierlenga MW; Keast DR; Longnecker MP
Environ Int; 2021 Jan; 146():106292. PubMed ID: 33395939
[TBL] [Abstract][Full Text] [Related]
40. Serum concentrations of perfluoroalkyl substances and their association with osteoporosis in a population in Jeddah, Saudi Arabia.
Banjabi AA; Li AJ; Kumosani TA; Yousef JM; Kannan K
Environ Res; 2020 Aug; 187():109676. PubMed ID: 32485360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
